AOD-9604 is a synthetic 16-amino-acid peptide corresponding to the C-terminal region of human growth hormone, residues 176 to 191, with an added N-terminal tyrosine. It was develop...
Weight Loss
Research on metabolic and weight-related peptides including GLP-1 receptor agonists, AOD-9604, and Tesamorelin. Covers preclinical studies on appetite regulation, lipolysis, insulin sensitivity, and metabolic pathway modulation.
AOD-9604 vs MOTS-C: Fat Metabolism Mechanism Comparison
Author : Spartan Research Team
AOD-9604 and MOTS-C represent two fundamentally different approaches to fat metabolism research. AOD-9604 is a synthetic fragment of human growth hormone designed to isolate the li...
Semax Peptide Deep Dive: BDNF Modulation and Cognitive Research
Author : Spartan Research Team
Semax peptide deep dive: ACTH-derived mechanism, BDNF upregulation via melanocortin receptors, cognitive research in animal models, neuroprotection in ischemia studies, and compari...
GLP-1 Sema vs GLP-2 Tirz: Research Mechanisms Compared
Author : Spartan Research Team
Two peptide compounds have reshaped metabolic research over the last decade. GLP-1 Sema and GLP-2 Tirz share a common target, the GLP-1 receptor, but they aren’t the same mol...
Skinny Fit Max Research Stack: GLP-3 Reta, MOTS-c and AOD-9604 Metabolic Synergy
Author : Spartan Research Team
Stack: Skinny Fit Max GLP-3(Reta) + MOTS-c + AOD-9604 | Preclinical and early-phase clinical research stack | For laboratory and in vitro research use only Three peptides. Three en...
Understanding the Skinny and Fit Peptide Stack: Multi-Pathway Metabolic Research
Author : Spartan Research Team
Updated May 2026. Understanding the Skinny and Fit peptide stack means tracking the latest preclinical research on all three compounds. This article covers current findings on mult...